T1	Participants 34 87	long-term exogenous subclinical hyperthyroid patients
T2	Participants 417 464	long-term exogenous subclinical hyperthyroidism
T3	Participants 687 814	25 patients with a history of differentiated thyroid carcinoma on long-term TSH-suppressive levothyroxine (l-T(4)) substitution
T4	Participants 929 976	Additionally 40 euthyroid controls were studied
T5	Participants 1547 1584	Prolonged subclinical hyperthyroidism
